Prolexys Pharmaceuticals' Unattributed VC Round

Prolexys Pharmaceuticals raised a round of funding on April 13, 2001. Investors include New Venturetec.

Prolexys Pharmaceuticals is a developer of cancer and cardiovascular small molecule drugs.…

Articles about Prolexys Pharmaceuticals' Unattributed VC Round: